Johnson & Johnson (NYSE: JNJ)
You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Johnson & Johnson Return vs. S&P
|1 Year||5 Year||5 Year Annualized||Since IPO|
Johnson & Johnson Company Info
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and MedTech. The Consumer Health segment includes products focused on personal healthcare used in the Skin Health/Beauty, Over-the-Counter medicines, Baby Care, Oral Care, Women’s Health and Wound Care markets. The Pharmaceutical segment focuses on therapeutic areas, such as immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The MedTech segment offers products used in the interventional solutions. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.
News & Analysis
These two stocks look like the best options among the Dow Jones Industrial Average's 30 components right now.
These two Dow Jones components have handed out more than 100 years of dividend hikes combined.
Adding these well-respected dividend payers to your portfolio could give you a stream of passive income that grows throughout your retirement years.
These time-tested Buffett stocks are clear-as-day values hiding in plain sight.
You'll want to follow Buffett's lead and hold on to these stocks forever.
You can take these companies' dividends straight to the bank.
Biotech-giant Amgen aims to launch a rival.
We also take a look at Chewy's growth initiatives.
Plus, we run through some shortcuts that could help you with your financial planning.
Plus, a look at the 4% rule and a common misconception about retirement spending.
Plus a look at what to like about Johnson & Johnson.
JNJ earnings call for the period ending December 31, 2022.
JNJ earnings call for the period ending September 30, 2022.
JNJ earnings call for the period ending June 30, 2022.
JNJ earnings call for the period ending March 31, 2022.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.